EUVIMEDEUVIMED entdecken
KommentarOpen Access · CC BY 4.0

Chromosomal instability induced by CRISPR/Cas9: implications for pancreatic cancer therapy

Li-Chan Chang, Christine E Eyler, Chang-Lung Lee

Journal of Clinical Investigation · 15.05.2026 · 136 (10)

DOI: 10.1172/jci206028 ↗

Kurz gefasst

Kommentar in der Zeitschrift Journal of Clinical Investigation, online erschienen am 15.05.2026. Verfasst von Li-Chan Chang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology and. Hauptthemen laut MEDLINE: Chromosomal Instability, Pancreatic Neoplasms, CRISPR-Cas Systems. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clinical management of pancreatic cancer (PC) remains severely limited, primarily due to the complex tumor microenvironment. Emerging DNA damage–targeted strategies have demonstrated considerable therapeutic potential in PC. In this issue of the JCI , Teh et al. employed cancer-specific multitarget sgRNAs to induce DNA double-strand breaks (DSBs), resulting in lethal effects in PC cells. Integrative bioinformatic and cytogenetic analyses revealed that CRISPR/Cas9-mediated DSBs provoked persistent chromosomal instability, ultimately leading to chromosome catastrophe and cell death. Compared with equivalent radiation-induced DSBs, these sgRNAs exhibited superior cytotoxicity and were able to eliminate cells resistant to a specific sgRNA via subsequent targeting at distinct genomic sites, highlighting a promising and innovative precision therapeutic approach for clinical treatment of PC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chromosomal InstabilityPancreatic NeoplasmsCRISPR-Cas SystemsHumansDNA Breaks, Double-StrandedAnimals

Autor:innen und Institutionen

  • Department of Radiation Oncology and.
  • Department of Pathology, Duke University School of Medicine, Durham, North Carolina, USA.

Zitieren

APA

Chang, L. C., Eyler, C. E., & Lee, C. L. (2026). Chromosomal instability induced by CRISPR/Cas9: implications for pancreatic cancer therapy. Journal of Clinical Investigation, 136(10). https://doi.org/10.1172/jci206028

Vancouver

Chang LC, Eyler CE, Lee CL. Chromosomal instability induced by CRISPR/Cas9: implications for pancreatic cancer therapy. Journal of Clinical Investigation. 2026;136(10). doi:10.1172/jci206028

BibTeX
@article{Chang2026,
  author = {Chang, Li-Chan and Eyler, Christine E and Lee, Chang-Lung},
  title = {Chromosomal instability induced by CRISPR/Cas9: implications for pancreatic cancer therapy},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  volume = {136},
  number = {10},
  doi = {10.1172/jci206028}
}
Kostenlos starten →